# Biomarkers in Parkinsonian Syndromes

> **NCT02114242** · — · UNKNOWN · sponsor: **University Hospital, Bordeaux** · enrollment: 100 (estimated)

## Conditions studied

- Parkinsonian Syndromes
- Parkinson's Disease
- Multiple System Atrophy
- Progressive Supranuclear Palsy

## Interventions

- **OTHER:** CSF, blood and urine sampling
- **OTHER:** clinical measures of disease severity and progression

## Key facts

- **NCT ID:** NCT02114242
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12-16
- **Primary completion:** 2023-12-16
- **Final completion:** 2025-12-16
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02114242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02114242, "Biomarkers in Parkinsonian Syndromes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02114242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*